Tags

Type your tag names separated by a space and hit enter

Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013.
Ethiop J Health Sci. 2016 Jul; 26(4):381-8.EJ

Abstract

BACKGROUND

Leishmaniasis covers a range of clinical manifestations. Estimation of the burden of leishmaniasis may help guide healthcare management personnel and policy-makers in applying effective interventions. The present study aimed to calculate the incidence and burden of cutaneous and visceral leishmaniasis in Iran in 2013.

METHODS

To evaluate the epidemiological aspects of the disease in Iran, published studies over the past 20 years were searched and the viewpoints of relevant specialists in Iran were obtained. Data were collected from the Ministry of Health and from the Tehran University of Medical Sciences. To calculate years of life lost due to premature death, standard expected years of life lost was used. Standard life table of Global Burden of Disease (GBD) 2010 with the life expectancy of 86.02 years for both sexes was used to calculate the remaining potential years of life at any age from death.

RESULTS

The overall incidence of cutaneous and visceral leishmaniasis was calculated as 22 and 0.092 per 100000 population of Iran, respectively. The burden of leishmaniasis was 99.5 years: 95.34 and 4.16 years for cutaneous and visceral, respectively. Sensitivity was analyzed and deaths predicted by the Institute of Health Metrics and Evaluation added, the burden of visceral leishmaniasis was 726 years.

CONCLUSION

The share of leishmaniasis burden in Iran is lower than the global burden of the disease. GBD 2010 standard method is recommended to calculate the burden of leishmaniasis in different countries and set local priorities on the basis of these measures.

Authors+Show Affiliations

Department of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.Department of Medical Parasitology and Mycology, School of Ppublic Health, Tehran University of Medical Sciences, Tehran, Iran.Department of Zoonoses, Communicable Disease Management Center, Ministry of Health, treatment and Education, Tehran, Iran.Department of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27587936

Citation

Heydarpour, Fatemeh, et al. "Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis in Iran, 2013." Ethiopian Journal of Health Sciences, vol. 26, no. 4, 2016, pp. 381-8.
Heydarpour F, Sari AA, Mohebali M, et al. Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013. Ethiop J Health Sci. 2016;26(4):381-8.
Heydarpour, F., Sari, A. A., Mohebali, M., Shirzadi, M., & Bokaie, S. (2016). Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013. Ethiopian Journal of Health Sciences, 26(4), 381-8.
Heydarpour F, et al. Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis in Iran, 2013. Ethiop J Health Sci. 2016;26(4):381-8. PubMed PMID: 27587936.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013. AU - Heydarpour,Fatemeh, AU - Sari,Ali Akbari, AU - Mohebali,Mehdi, AU - Shirzadi,Mohammadreza, AU - Bokaie,Saied, PY - 2016/9/3/entrez PY - 2016/9/3/pubmed PY - 2017/4/15/medline KW - Cutaneous leishmaniasis KW - Disability-adjusted life years KW - Incidence KW - Iran KW - Visceral leishmaniasis SP - 381 EP - 8 JF - Ethiopian journal of health sciences JO - Ethiop J Health Sci VL - 26 IS - 4 N2 - BACKGROUND: Leishmaniasis covers a range of clinical manifestations. Estimation of the burden of leishmaniasis may help guide healthcare management personnel and policy-makers in applying effective interventions. The present study aimed to calculate the incidence and burden of cutaneous and visceral leishmaniasis in Iran in 2013. METHODS: To evaluate the epidemiological aspects of the disease in Iran, published studies over the past 20 years were searched and the viewpoints of relevant specialists in Iran were obtained. Data were collected from the Ministry of Health and from the Tehran University of Medical Sciences. To calculate years of life lost due to premature death, standard expected years of life lost was used. Standard life table of Global Burden of Disease (GBD) 2010 with the life expectancy of 86.02 years for both sexes was used to calculate the remaining potential years of life at any age from death. RESULTS: The overall incidence of cutaneous and visceral leishmaniasis was calculated as 22 and 0.092 per 100000 population of Iran, respectively. The burden of leishmaniasis was 99.5 years: 95.34 and 4.16 years for cutaneous and visceral, respectively. Sensitivity was analyzed and deaths predicted by the Institute of Health Metrics and Evaluation added, the burden of visceral leishmaniasis was 726 years. CONCLUSION: The share of leishmaniasis burden in Iran is lower than the global burden of the disease. GBD 2010 standard method is recommended to calculate the burden of leishmaniasis in different countries and set local priorities on the basis of these measures. SN - 2413-7170 UR - https://www.unboundmedicine.com/medline/citation/27587936/Incidence_and_Disability_Adjusted_Life_Years__Dalys__Attributable_to_Leishmaniasis_In_Iran_2013_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27587936/ DB - PRIME DP - Unbound Medicine ER -